Compare FDMT & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FDMT | DNUT |
|---|---|---|
| Founded | 2013 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Food Chains |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 513.6M | 602.2M |
| IPO Year | 2019 | 2021 |
| Metric | FDMT | DNUT |
|---|---|---|
| Price | $8.77 | $3.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 6 |
| Target Price | ★ $34.13 | $4.72 |
| AVG Volume (30 Days) | 725.8K | ★ 2.4M |
| Earning Date | 04-13-2026 | 05-25-2026 |
| Dividend Yield | N/A | ★ 1.00% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $37,000.00 | ★ $1,522,616,000.00 |
| Revenue This Year | $21,227.03 | N/A |
| Revenue Next Year | $161.87 | $6.58 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.24 | $2.58 |
| 52 Week High | $12.34 | $5.92 |
| Indicator | FDMT | DNUT |
|---|---|---|
| Relative Strength Index (RSI) | 46.76 | 51.63 |
| Support Level | $8.11 | $3.11 |
| Resistance Level | $8.80 | $3.48 |
| Average True Range (ATR) | 0.56 | 0.19 |
| MACD | -0.12 | 0.05 |
| Stochastic Oscillator | 25.33 | 43.50 |
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.